37
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

      New England Journal of Medicine
      Massachusetts Medical Society

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Most cited references1

          • Record: found
          • Abstract: not found
          • Article: not found

          Clinical response, progression-free survival (PFS), and safety in patients (pts) with advanced melanoma (MEL) receiving nivolumab (NIVO) combined with ipilimumab (IPI) vs IPI monotherapy in CheckMate 069 study

            Bookmark

            Author and article information

            Journal
            New England Journal of Medicine
            N Engl J Med
            Massachusetts Medical Society
            0028-4793
            1533-4406
            September 24 2015
            September 24 2015
            : 373
            : 13
            : 1270-1271
            Article
            10.1056/NEJMc1509660
            26398076
            03f77a6d-1456-47dc-be1d-992ac15d4105
            © 2015
            History

            Comments

            Comment on this article